Study for Evaluation of Efficacy and Safety of SH L 749 to Indolent B-cell Non-Hodgkin's Lymphoma
Status:
Completed
Trial end date:
2005-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the antitumor effect and safety of the product
for relapsed or refractory indolent B-cell non-Hodgkin's lymphomas.